Dr. Verma is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Texas Tech University Health Sciences Center
3601 4th Street, TX 794
Lubbock, TX 79430Phone+1 214-499-1872Fax+1 214-645-2615
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Charleston Area Medical Center/CAMC Institute for Academic MedicineResidency, Internal Medicine, 1997 - 1999
King George's/CSM Medical CollegeClass of 1983
Certifications & Licensure
WV State Medical License 2024 - 2025
TX State Medical License 2003 - 2024
IA State Medical License 1999 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Publications & Presentations
PubMed
- 83 citationsA Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second-Line Treatment of Metastatic KRAS Mutant Colore...J. Randolph Hecht, Al B. Benson, Dmitry Vyushkov, Yingsi Yang, Johanna C. Bendell
The Oncologist. 2017-03-01 - 176 citationsCellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.Abdel Nasser Hosein, Huocong Huang, Zhaoning Wang, Kamalpreet Parmar, Wenting Du
JCI Insight. 2019-08-22 - 38 citationsBlocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the In Vitro Integrity of T Cells from Cancer Patients.Masato Kobayashi, Jin Sung Chung, Muhammad Shaalan Beg, Yull Edwin Arriaga, Udit Verma
Clinical Cancer Research. 2019-01-15
Grant Support
- Mechanisms Regulating HIV-1 Gene ExpressionNational Institute Of Allergy And Infectious Diseases2003–2005
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
